Jasna But Hadzic, Head of Department of Oncology at Faculty of Medicine University of Ljubljana and Radiation oncologist at Institute of Oncology, shared a post on LinkedIn:
“Strong Slovenian Presence at ESTRO 2025!
Slovenia is well represented at ESTRO 2025, with the Institute of Oncology Ljubljana and our collaborators contributing to cutting-edge oncology research and patient advocacy.
- Mini Oral Presentation.
- Gaber Plavc: Discussing variability in target selection and delineation in Head and Neck cancers – key to improving precision and outcomes.
- Lecture.
- Tanja Španič: Inspiring talk on patients as partners – a powerful reminder of the essential role of patient voices in shaping future healthcare.
- Poster Presentations.
- Ivica Ratoša & Jasna But Hadžić: Researching ALT region irradiation and lymphedema in breast cancer.
- Ajra Šečerov Ermenc: Analyzing the impact of dose prescription in SBRT.
- Staša Jelerčič: Contributing to Re-CARE cohort analysis.
- Eva Ćirić & Jasna But Hadžić: Evaluating the impact of immunotherapy in oligometastatic NSCLC.
- Miha Oražem: Exploring TNT sequencing and lymphopenia in rectal cancer.
- Helena Barbara Zobec Logar: Investigating SABR in very-high-risk prostate cancer – advancing care for aggressive disease.
A huge congratulations to all presenters! Your work and advocacy elevate the international profile of Slovenian oncolgy and patient engagement.”
More posts featuring ESTRO on OncoDaily.
